Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 146NIH 65NETWORK 31INDUSTRY 28OTHER_GOV 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 2Gastrointestinal 1

Conditions

Breast Neoplasms 196Neoplasms 104Colorectal Neoplasms 91Stomach Neoplasms 80Uterine Cervical Neoplasms 70Carcinoma, Non-Small-Cell Lung 67Carcinoma, Hepatocellular 53Lung Neoplasms 48Prostatic Neoplasms 47Rectal Neoplasms 46Esophageal Neoplasms 39Pancreatic Neoplasms 37Colonic Neoplasms 36Ovarian Neoplasms 35Recurrence 33Head and Neck Neoplasms 33Neoplasm Metastasis 28Motor Activity 28Multiple Myeloma 27Small Cell Lung Carcinoma 26Melanoma 25Polycystic Ovary Syndrome 24Lymphoma, Non-Hodgkin 24Lymphoma 24Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Pain 20Brain Neoplasms 20Nasopharyngeal Carcinoma 18Hematologic Neoplasms 17

Interventions

Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Medulloblastoma × Clear all
NCT06898684 2025-12-16

MOVE

Vastra Gotaland Region

Phase NA Recruiting
15 enrolled
CNS

Medulloblastoma, Motor Activity

NCT04270461 2020-10-22

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Jiujiang University Affiliated Hospital

Phase 1 Withdrawn
CNSGastrointestinal

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡